Carregant...
Current pharmacological treatments for SARS-COV-2: A narrative review
The novel coronavirus, later identified as SARS-CoV-2, originating from Wuhan in China in November 2019, quickly spread around the world becoming a pandemic. Despite the knowledge of previous coronaviruses, such as those responsible for the SARS and MERS-CoV epidemic, there is no drug or prophylaxis...
Guardat en:
| Publicat a: | Eur J Pharmacol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier B.V.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7320862/ https://ncbi.nlm.nih.gov/pubmed/32603692 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejphar.2020.173328 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|